Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 19;10(4):e00999.
doi: 10.14309/crj.0000000000000999. eCollection 2023 Apr.

Hepatic Amyloidosis With Multiorgan Involvement

Affiliations
Case Reports

Hepatic Amyloidosis With Multiorgan Involvement

Robert J Duve et al. ACG Case Rep J. .

Abstract

Amyloidosis is a diverse entity that poses both diagnostic and treatment challenges. Whether systemic or local, amyloidosis has varied manifestations including occasional hepatic involvement. Hepatic amyloidosis, although rare, should be on the differential for those with unexplained hepatomegaly, cholestasis, alkaline phosphatase elevations, other associated organomegaly, and those with certain epidemiologic risks. In this study, we report a case of a man with systemic amyloid light chain amyloidosis with multiorgan involvement, acute liver injury, cholestasis, nephrotic syndrome, cardiomegaly, and bleeding diathesis.

Keywords: AL amyloid; acute liver failure; hepatic; light-chain; ight chain amyloidosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hematoxylin and eosin section of renal biopsy specimen 40×.
Figure 2.
Figure 2.
Hematoxylin and eosin section of renal biopsy specimen 40×.
Figure 3.
Figure 3.
Renal biopsy specimen staining positive for Congo Red 100×.
Figure 4.
Figure 4.
Renal biopsy specimen staining positive for Congo Red 100×.

References

    1. Dahiya DS, Kichloo A, Singh J, Albosta M, Wani F. Gastrointestinal amyloidosis: A focused review. World J Gastrointest Endosc. 2021;13(1):1–12. - PMC - PubMed
    1. Bustamante JG, Zaidi SRH. Amyloidosis. In: StatPearls. StatPearls Publishing: Treasure Island, FL, 2022.
    1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–96. - PubMed
    1. Baker KR, Rice L. The amyloidoses: Clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012;8(3):3–7. - PMC - PubMed
    1. Alexander KM, Orav J, Singh A, et al. . Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: Potential underdetection of cardiac amyloidosis. JAMA Cardiol. 2018;3(9):865–70. - PMC - PubMed

Publication types